BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27641066)

  • 1. KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness.
    Cheray M; Bessette B; Lacroix A; Mélin C; Jawhari S; Pinet S; Deluche E; Clavère P; Durand K; Sanchez-Prieto R; Jauberteau MO; Battu S; Lalloué F
    J Cell Mol Med; 2017 Feb; 21(2):244-253. PubMed ID: 27641066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.
    Dai B; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
    Oncol Rep; 2016 Jul; 36(1):173-80. PubMed ID: 27176716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
    Wang XQ; Tao BB; Li B; Wang XH; Zhang WC; Wan L; Hua XM; Li ST
    Oncotarget; 2016 Jan; 7(3):2354-66. PubMed ID: 26506595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
    Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
    Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells.
    Cheray M; Petit D; Forestier L; Karayan-Tapon L; Maftah A; Jauberteau MO; Battu S; Gallet FP; Lalloué F
    Cancer Lett; 2011 Dec; 312(1):24-32. PubMed ID: 21899947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma.
    Ahmadov U; Picard D; Bartl J; Silginer M; Trajkovic-Arsic M; Qin N; Blümel L; Wolter M; Lim JKM; Pauck D; Winkelkotte AM; Melcher M; Langini M; Marquardt V; Sander F; Stefanski A; Steltgens S; Hassiepen C; Kaufhold A; Meyer FD; Seibt A; Kleinesudeik L; Hain A; Münk C; Knobbe-Thomsen CB; Schramm A; Fischer U; Leprivier G; Stühler K; Fulda S; Siveke JT; Distelmaier F; Borkhardt A; Weller M; Roth P; Reifenberger G; Remke M
    Cell Death Dis; 2021 Sep; 12(10):885. PubMed ID: 34584066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate.
    Park H; Ohshima K; Nojima S; Tahara S; Kurashige M; Hori Y; Okuzaki D; Wada N; Ikeda JI; Morii E
    Lab Invest; 2018 Apr; 98(4):449-461. PubMed ID: 29467457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.
    Pinet S; Bessette B; Vedrenne N; Lacroix A; Richard L; Jauberteau MO; Battu S; Lalloué F
    Oncotarget; 2016 Aug; 7(31):50349-50364. PubMed ID: 27385098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
    Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
    Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.
    Nakata S; Imagawa A; Miyata Y; Yoshikawa A; Kozawa J; Okita K; Funahashi T; Nakamura S; Matsubara K; Iwahashi H; Shimomura I
    Immunol Lett; 2013; 156(1-2):149-55. PubMed ID: 24177169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
    Yang L; Yan Z; Wang Y; Ma W; Li C
    Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling.
    Nie Z; Cheng D; Pan C; Wei Z; Wang C; Wang C
    Biochem Biophys Res Commun; 2021 Jun; 556():114-120. PubMed ID: 33839406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
    Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROX1 promotes human glioblastoma cell proliferation and invasion via activation of the nuclear factor-κB signaling pathway.
    Xu X; Wan X; Wei X
    Mol Med Rep; 2017 Feb; 15(2):963-968. PubMed ID: 28035380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
    Peng G; Liao Y; Shen C
    Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
    Fuentes-Fayos AC; Vázquez-Borrego MC; Jiménez-Vacas JM; Bejarano L; Pedraza-Arévalo S; L-López F; Blanco-Acevedo C; Sánchez-Sánchez R; Reyes O; Ventura S; Solivera J; Breunig JJ; Blasco MA; Gahete MD; Castaño JP; Luque RM
    Brain; 2020 Dec; 143(11):3273-3293. PubMed ID: 33141183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yes and PI3K bind CD95 to signal invasion of glioblastoma.
    Kleber S; Sancho-Martinez I; Wiestler B; Beisel A; Gieffers C; Hill O; Thiemann M; Mueller W; Sykora J; Kuhn A; Schreglmann N; Letellier E; Zuliani C; Klussmann S; Teodorczyk M; Gröne HJ; Ganten TM; Sültmann H; Tüttenberg J; von Deimling A; Regnier-Vigouroux A; Herold-Mende C; Martin-Villalba A
    Cancer Cell; 2008 Mar; 13(3):235-48. PubMed ID: 18328427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.